<scp>CD48</scp> Is a Robust Marker and a Useful Addition for Assessment of Measurable Residual Disease in T‐Cell Acute Lymphoblastic Leukemia
CD48 demonstrates consistent under-expression in T-lymphoblasts compared to mature T cells and NK cell cells, supporting its use as a reliable and informative marker for MRD detection in T-ALL. Its inclusion would enhance the accuracy of flow cytometry-based MRD panels.
Authors
- Praveen Rishi nee Sharma (ORCID: https://orcid.org/0000-0002-2980-8914)
- Nabhajit Mallik (ORCID: https://orcid.org/0000-0003-0791-9426)
- Tharageswari Srinivasan
- B. Lal
- Sreejesh Sreedharanunni (ORCID: https://orcid.org/0000-0003-2626-4154)
- Amita Trehan
- Parveen Bose
- Arun Kumar
- Man Updesh Singh Sachdeva
Institutions
- Post Graduate Institute of Medical Education and Research (IN)
Publication Details
- Journal
- European Journal Of Haematology
- Published
- 2025-09-13
- DOI
- https://doi.org/10.1111/ejh.70035
- Citations
- 1
- Primary Topic
- Acute Lymphoblastic Leukemia research
- Type
- article
- Field-Weighted Citation Impact
- 1.88